Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System' Published by the United States Patent and Trademark Office Following Recent Issuance NoticeAccesswire • 02/16/22
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark OfficeAccesswire • 01/28/22
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent TechnologyAccesswire • 01/18/22
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl PatchAccesswire • 01/10/22
Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting FirmAccesswire • 01/05/22
Nutriband stock more than doubles in very active trading after a full patent was issued in South KoreaMarket Watch • 12/31/21
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" ApplicationAccesswire • 12/31/21
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing ServicesAccesswire • 12/21/21
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) FentanylAccesswire • 11/16/21
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7MAccesswire • 10/22/21
NTRB Stock: 11 Things for Nutriband Investors to Know About the Covid-19 Antibody Indicator PatchInvestorPlace • 10/12/21
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator PatchAccesswire • 10/12/21
WallachBeth Capital Announces Completion of a $6.6 Million Underwritten Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital MarketPRNewsWire • 10/06/21
WestPark Capital Announces Completion of a $6.6 Million Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital MarketBusiness Wire • 10/05/21